The Challenges of Pediatric Drug Development

INTRODUCTION AND BACKGROUND: “Pediatric Drug Development” is being used to describe not the development of drugs for children, but rather the planning & conducting separate efficacy and safety (E&S) studies requested/demanded by regulatory authorities designed to produce pediatric labels. Pe...

Descripción completa

Detalles Bibliográficos
Autor principal: Rose, Klaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Budapest Pediatric Development Special Issue
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677568/
https://www.ncbi.nlm.nih.gov/pubmed/31388368
http://dx.doi.org/10.1016/j.curtheres.2019.01.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677568/
https://www.ncbi.nlm.nih.gov/pubmed/31388368
http://dx.doi.org/10.1016/j.curtheres.2019.01.007

Ejemplares similares